DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million on November 16, 2020. Under the terms of the offer, $0.4 will be paid per share net to the seller in cash without interest and less applicable withholding taxes. Tender offer is subject to minimum acceptance of 50.1%. Tender offer commencement has started and shall last till January 21, 2021. As on January 21, 2021, holders of 5,695,775 had tendered their securities had tendered their securities. and this offer extended till January 28, 2021. DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million on January 28, 2021. American Stock Transfer & Trust Company, LLC acted as depositary and paying agent on the tender offer. D.F. King & Co., Inc acted as information agent on the tender offer. White Oak Healthcare Finance announced it acted as sole lender and administrative agent of a senior credit facility to support the acquisition of Parnell Pharmaceuticals Holdings, Ltd by DW Healthcare Partners.